November 20th, 2026Oral SERDs: What Giredestrant Signals for NursesAfter a run of 2026 oral SERD approvals, Erica L. Mayer, MD, MPH, discusses ESR1 testing and a possible adjuvant role for giredestrant.Read more
November 20th, 2026SONO 2026: Kelsey Martin on a Busy Year for Breast Cancer ApprovalsKelsey Martin, AG-ACNP-BC, AOCNP, says new breast cancer approvals in 2026 are bringing targeted treatments to patients earlier and closer to home.Read more
November 19th, 2026SONO 2026: Donna Catamero on Defining Cure as Myeloma Outcomes ImproveDonna D. Catamero, ANP-BC, OCN, CCRC, says CAR T-cell and bispecific therapies have myeloma teams discussing cure, with nurses on the front line.Read more
November 19th, 2026ESMO and EONS 2026: Workforce and Therapy Takeaways for Oncology NursesAn ONS nursing practice leader shares takeaways from EONS19 at ESMO 2026, from workforce sustainability to new therapies and subcutaneous care.Read more
November 17th, 2026SONO 2026: Beth Sandy Ties NSCLC Treatment Updates to Nursing Toxicity CareBeth Sandy, MSN, CRNP, FAPO, reviewed ADCs, immunotherapy, and targeted therapy in NSCLC with a focus on what nurses should monitor.Read more
November 12th, 2026SONO 2026: Nurses Remain the Front Line as Cancer Therapies EvolveAt the 10th Annual School of Nursing Oncology, faculty said nurses need fast, disease-specific updates to educate patients and manage novel therapies.Read more
November 10th, 2026Oncology Nurse Burnout: An Employer Blueprint From EONS19An ONS review presented at EONS19 outlines 7 system-level employer strategies to curb oncology nurse burnout and improve retention.Read more
November 22nd, 2026New ASH Myelofibrosis Guidelines: Key Points for Nurses and APPsA guideline panelist explains expanded molecular testing, early transplant referral, anemia strategies, and symptom-driven JAK inhibitor use.Read more